EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Radioprotective effect of the anti-diabetic drug metformin

Silvia Siteni iD, Summer Barron, Krishna Luitel, Jerry W Shay iD

PLOS ONE · 23.07.2024 · 19 (7) · e0307598

DOI: 10.1371/journal.pone.0307598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 23.07.2024. Verfasst von Silvia Siteni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. Hauptthemen laut MEDLINE: Metformin, Radiation-Protective Agents, Hypoglycemic Agents, DNA Damage. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NASA, Cancer Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin is a biguanide currently used in the treatment of diabetes mellitus type 2. Besides its anti-glycemic effects, metformin has been reported to induce different cellular pleiotropic effects, depending on concentration and time of treatment. Here we report one administration of metformin (0.5 mM) has radioprotective effects in vitro on BJ human fibroblasts, increasing DNA damage repair and increasing SOD1 expression in the nucleus. Importantly, metformin (200 mg/kg) pre-administration for only 3 days in wild type 129/sv mice, decreases the formation of micronuclei in bone marrow cells and DNA damage in colon and lung tissues compared to control irradiated mice at sub-lethal and lethal doses, increasing the overall survival fraction by 37% after 10Gy total body irradiation. We next pre-treated with metformin and then exposed 129/sv mice, to a galactic cosmic rays simulation (GCRsim), at the NASA Space Radiation Laboratory (NSRL). We found metformin pre-treatment decreases the presence of bone marrow micronuclei and DNA damage in colon and lung tissues and an increase of 8-oxoguanine DNA glycosylase-1 (OGG1) expression. Our data highlight a radioprotective effect of metformin through an indirect modulation of the gene expression involved in the cellular detoxification rather than its effects on mitochondria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminRadiation-Protective AgentsHypoglycemic AgentsDNA DamageAnimalsMiceHumansDNA RepairFibroblastsSuperoxide DismutaseCell LineMicronucleus TestsLungMale

Substanzen

MetforminRadiation-Protective AgentsHypoglycemic AgentsSuperoxide Dismutase

Autor:innen und Institutionen

  • Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

ORCID-Profile: Silvia Siteni, Jerry W Shay

Förderung

  • NCI NIH HHS
  • NASA
  • Cancer Training Program
  • NIH
  • Harold Simmons NCI Designated Comprehensive Cancer Center Support Grant

Zitieren

APA

Siteni, S., Barron, S., Luitel, K., & Shay, J. W. (2024). Radioprotective effect of the anti-diabetic drug metformin. PLOS ONE, 19(7), e0307598. https://doi.org/10.1371/journal.pone.0307598

Vancouver

Siteni S, Barron S, Luitel K, Shay JW. Radioprotective effect of the anti-diabetic drug metformin. PLOS ONE. 2024;19(7):e0307598. doi:10.1371/journal.pone.0307598

BibTeX
@article{Siteni2024,
  author = {Siteni, Silvia and Barron, Summer and Luitel, Krishna and Shay, Jerry W},
  title = {Radioprotective effect of the anti-diabetic drug metformin},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {7},
  pages = {e0307598},
  doi = {10.1371/journal.pone.0307598}
}
Kostenlos starten →